You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 204611 - 204620 of 207712 results
  1. CRISPR-based Diagnostic for Parasites

    SBC: BIOLOGICAL MIMETICS, INC.            Topic: 119

    To develop a sensitive point-of-care diagnostic for an important neglected tropical disease, Leishmaniasis.

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. CRISPR-based Tropical Infection Diagnostics

    SBC: CHROMOLOGIC LLC            Topic: 119

    To develop a device for the detection of malaria.

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. SBIR PHASE I- TOPIC 123

    SBC: LIFETIME OMICS, INC.            Topic: 123

    To implement a pilot version of FAIRLYZ, a novel dataset profiling and registry solution.

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. TOOLKIT FOR LEARNING AND PREDICTING ALCOHOL USE PATTERNS (SBIR PHASE II, TOPIC 019)

    SBC: BIOREALM, LLC            Topic: 19

    This contract is for a project titled, ""Toolkit for Learning and Predicting Alcohol Use Patterns (SBIR Phase II, Topic 019), and the purpose for this project is for creating a platform to accelerate alcohol research that consists of developing an innovative toolkit for learning and predicting alcohol use patterns and creating machine learning algorithms that are capable of analyzing high dimensio ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig

    SBC: GLYCOSCIENTIFIC, L.L.C.            Topic: 118

    GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in the guinea pig. Once the antibodies are produced, the Offeror will use them to evaluate the cytokines in TB infected and non-infected guinea pigs. The production of these crucial immunological reagents ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease

    SBC: SILVER LAKE RESEARCH CORPORATION            Topic: 118

    Silver Lake proposes to fully characterize mAb against 6 targets produced in their three concurrent Phase 1 projects that are relevant in models of disease and inflammation, determine their usability in multiple assay types, develop user protocols for each assay type and mAb, produce quality-controlled reagents, produce multiple conjugates for each mAb, and make all reagents available for the rese ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tuberculosis

    SBC: VIA THERAPEUTICS, LLC            Topic: 97

    To develop and test a low-cost, easy-to-administer drug formulation intended for use in treating rifampicin-resistant pulmonary tuberculosis in pediatric patient populations.

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. CLINICAL VERIFICATION AND VALIDATION OF A WEARABLE NEAR-INFRARED BLOOD ALCOHOL CONTENT MONITOR.

    SBC: VIVONICS INC            Topic: 18

    CLINICAL VERIFICATION AND VALIDATION OF A WEARABLE NEAR-INFRARED BLOOD ALCOHOL CONTENT MONITOR.

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Reagents for Immunologic Analysis of Under-represented Mammalian Models

    SBC: INTEGRAL MOLECULAR INC            Topic: 118

    Integral Molecular proposes to generate a large panel of pan-reactive monoclonal antibodies (mAbs) against immune cell markers to be used instudies of immune function and responses in nine underrepresented mammalian models. Since certain mammalian models display many features of human immunity but are similarly underutilized due to lack of immunologic reagents, development of cross-reacting antibo ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. FY23. SBIR TOPIC 167 PHASE I: ULTRAPORTABLE LAB-ON-A-CHIP BIOSENSOR SYSTEM FOR RAPID POSTMORTEM TOXICOLOGY. PERIOD OF PERFORMANCE: 9/27/23-9/26/24

    SBC: PORTABLE DIAGNOSTIC SYSTEMS INC            Topic: 167

    Currently, suspected drug overdoses represent more than 1 in 6 death investigations, and both coroner and medical examiner offices are facing overwhelming caseloads that require comprehensive toxicology analysis. Therefore, there is a critical and immediate need to improve the workflow in suspected fatal overdose cases with new postmortem toxicology screening tools. This Phase I project from Porta ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government